Tuberculosis burden in indigenous population of Paraguay from 2018 to 2022
DOI:
https://doi.org/10.18004/mem.iics/1812-9528/2023.e21162301Keywords:
tuberculosis, mortality, incidence, indigenousAbstract
This study aims to report the epidemiological characterization, incidence, mortality and prognostic factors of tuberculosis in indigenous patients of Paraguay from 2018 to 2022. A retrospective cohort study was carried out with data extracted from the National Tuberculosis Program from January 2018 to June 2022. The clinical records of 1659 indigenous patients were included in the study. The indigenous population with tuberculosis in the period 2018-2022 was between 0 and 20 years old (25.4%), mostly female (54.6%), residing in Presidente Hayes (22.4%), and was from the rural area (74.3%), of the Mbya ethnic group (20.4%). The diagnosis was bacteriological in 69.2%, 96.1% had pulmonary location, 94.5% of the study population started treatment and 1.1% presented drug-resistance, while 88.3% corresponded to new cases. The highest number of new cases of tuberculosis in indigenous people was 336 in 2019. The incidence of tuberculosis was associated with age and area of residence, being more incident in the youngest and in the Presidente Hayes area. A total of 11.2% died, and the highest number of deaths occurred in 2019 with 47 cases (14%). We observed that the elderly, who did not start treatment, and who were coinfected with HIV were more likely to die from tuberculosis. The number of new cases and mortality from tuberculosis is high in the Paraguayan indigenous population. Age and coinfection with HIV continue to be risk factors for mortality.
Downloads
References
Giménez B MJ. Prevalencia de tuberculosis en indígenas de Caaguazú, 2015 a 2017 [Internet] [Thesis]. FCM-UNCA; 2018 [accessed 2020 Jul 7]. Available from: https://repositorio.fcmunca.edu.py/xmlui/handle/123456789/38
OMS. TB en las Américas. Informe Regional 2019. In: https://iris.paho.org/bitstream/handle/10665.2/55047/9789275324479_spa.pdf?sequence=4&isAllowed=y
OMS. Tuberculosis. Datos y cifras. (2021 abril 2023) .
Sarmiento JMH, Tegaisa LV, Salazar TV. Tuberculosis en comunidades indígenas del Chocó, Colombia. Análisis epidemiológico y perspectivas para disminuir su incidencia. Enfermedades Infecc Microbiol [Internet]. 2020 Apr 17 [accessed 2020 Jul 7];38(4):104-14. Available from: Available from: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=92779
Ferreira R AO. Caracterización clínica y epidemiológica de pacientes con tuberculosis del Departamento de Caaguazú, 2014 - 2017 [Internet] [Thesis]. FCM-UNCA; 2018 [accessed 2020 Jul 7]. Available from: Available from: https://repositorio.fcmunca.edu.py/xmlui/handle/123456789/31
Argumedo Rios MM, Solano Rossi MA. Factores asociados a la tuberculosis en poblaciones indígenas de América durante el periodo 2005 a 2015. 2016 [accessed 2020 Jul 7]; Available from: Available from: https://digitk.areandina.edu.co/handle/areandina/657
Culqui DR, Trujillo OV, Cueva N, Aylas R, Salaverry O, Bonilla C. Tuberculosis en la población indígena del Perú 2008. Rev Peru Med Exp Salud Publica [Internet]. 2010 Mar [accessed 2020 Dec 11]; 27(1): 8-15. Available from: Available from: http://www.scielo.org.pe/scielo.php?script=sci_abstract&pid=S1726-46342010000100003&lng=es&nrm=iso&tlng=pt
Culqui D, Zavaleta C, Romero J, Bonilla C, Trujillo O, Cueva N. Tuberculosis en poblaciones indígenas del Perú: Los Aimaras del Perú, 2000-2005. Rev Peru Epidemiol. 2009; 13(1): 1-6.
Aguirre S, Sanabria GE, Sequera G, Méndez J, Aguilar G, Rolon AO, et al. Factores asociados a la mortalidad por tuberculosis en indígenas en Paraguay, 2014 a 2019. Rev Chil Infectol [Internet]. 2022 Sep 5 [accessed 2022 Nov 24]; 39(5). Available from: Available from: https://www.revinf.cl/index.php/revinf/article/view/1342
Paiva BL, Azeredo JQ, Nogueira LMV, Santos B de O, Rodrigues ILA, Santos MN de A. Spatial distribution of tuberculosis in indigenous and non-indigenous populations in the state of Pará, Brazil, 2005-2013. Esc Anna Nery [Internet]. 2017 Aug 28 [accessed 2021 Oct 19];21. Available from: Available from: http://www.scielo.br/j/ean/a/gQHwCRSxJJS6p3CrMYtWxCq/abstract/?lang=en
Romero-Amaro Z, Salazar P J, Bracho M A, Atencio T R, Romero-Gori N, Montiel U C. Prevalencia de tuberculosis pulmonar en pacientes indígenas y no indígenas del estado Zulia durante el periodo 1996-2005. Kasmera [Internet]. 2008 Dec [accessed 2021 Oct 19];36(2):159-68. Available from: Available from: http://ve.scielo.org/scielo.php?script=sci_abstract&pid=S0075-52222008000200008&lng=es&nrm=iso&tlng=pt
Sanhueza-Sanzana C, Kerr L, Kendall C. Mortalidad por SIDA y coinfección por tuberculosis-VIH en la Cohorte Chilena de SIDA de 2000-2017. Cad Saúde Pública [Internet]. 2021 Jun 23 [accessed 2021 Aug 20];37. Available from: Available from: http://www.scielo.br/j/csp/a/D5Mk3pXTXXDzpxqMbGfxKTD/abstract/?format=html&lang=es
Eldholm V, Rieux A, Monteserin J, Lopez JM, Palmero D, Lopez B, et al. Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. Elife. 2016; eLife2016 ;5:e16644.
Caminero JA, Cayla JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. Arch Bronconeumol [Internet]. 2017 Sep 1 [accessed 2021 Sep 17];53(9):501-9. Available from: Available from: https://www.sciencedirect.com/science/article/pii/S0300289617300509
Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health [Internet]. 2020 Sep 1 [accessed 2020 Oct 10];8(9): e1132-41. Available from: Available from: http://www.sciencedirect.com/science/article/pii/S2214109X20302886
Estigarribia G, Aguirre S, Sequera G, Méndez J, Aguilar G, Sosa N, et al. Vigilancia de la resistencia del Mycobacterium tuberculosis a los fármacos en Paraguay, 2014 a 2017. An Fac Cienc Médicas Asunción [Internet]. 2022 Dec [accessed 2022 Nov 24];55(3): 27-34. Available from: Available from: http://scielo.iics.una.py/scielo.php?script=sci_abstract&pid=S1816-89492022000300027&lng=en&nrm=iso&tlng=es
Alba Álvarez LM, García García JM, Pérez Hernández MD, Martínez González S, Palacios Gutiérrez JJ. Utilidad de los métodos fenotípicos y genotípicos en el estudio de resistencias de Mycobacterium tuberculosis a fármacos antituberculosos de primera línea. Arch Bronconeumol [Internet]. 2017 Apr 1 [accessed 2021 Nov 8];53(4):192-8. Available from: Available from: https://www.sciencedirect.com/science/article/pii/S0300289616302411
Caminero JA, Cayla JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos - ScienceDirect. Archivos de Bronconeumología [Internet]. 2017 [accessed 2020 Mar 4]; 53(9): 501-9. Available from: Available from: https://www.sciencedirect.com/science/article/pii/S0300289617300509
